Pharma companies are making commitments to environmental sustainability, yet practical barriers are making it hard to deliver on that commitment.
That’s according to a recent report out from global consulting firm Oliver Wyman that identified ways in which pharma companies can start to implement changes now that will have a large impact on the climate in years to come.
